Abstract
Opioid medications are increasingly used to treat chronic pain. Opioid-associated respiratory depression, and their potential to cause nocturnal apneas, is increasingly recognized as a major contributor to nocturnal hypoxemia and sleep-disordered breathing. Given the widespread use of opioids, understanding their mechanism of action and their potential to cause adverse effects particularly during sleep is critical. This article reviews the salient features of the physiologic control of respiration and sleep, and the role opioids play in altering that regulation. Additionally, we summarize the evidence regarding the association between opioid use and sleep-disordered breathing and explore treatment modalities for opioid-associated nocturnal respiratory depression and apneas.
Keywords: Opioids, sleep-disordered breathing, sleep apnea, central sleep apnea, control of breathing, apnea, non-mailgnant, retrotrapezoid, escalation, synergistic, orphanin, hypoxia, hypercarbia, enkephalins, hydromorphone, methadone, narcotics, adenotonsillectomy, dexmedetomidine
Current Pharmaceutical Design
Title: Opioids, Sleep, and Sleep-Disordered Breathing
Volume: 17 Issue: 15
Author(s): Moshe Zutler and Jon-Erik C. Holty
Affiliation:
Keywords: Opioids, sleep-disordered breathing, sleep apnea, central sleep apnea, control of breathing, apnea, non-mailgnant, retrotrapezoid, escalation, synergistic, orphanin, hypoxia, hypercarbia, enkephalins, hydromorphone, methadone, narcotics, adenotonsillectomy, dexmedetomidine
Abstract: Opioid medications are increasingly used to treat chronic pain. Opioid-associated respiratory depression, and their potential to cause nocturnal apneas, is increasingly recognized as a major contributor to nocturnal hypoxemia and sleep-disordered breathing. Given the widespread use of opioids, understanding their mechanism of action and their potential to cause adverse effects particularly during sleep is critical. This article reviews the salient features of the physiologic control of respiration and sleep, and the role opioids play in altering that regulation. Additionally, we summarize the evidence regarding the association between opioid use and sleep-disordered breathing and explore treatment modalities for opioid-associated nocturnal respiratory depression and apneas.
Export Options
About this article
Cite this article as:
Zutler Moshe and C. Holty Jon-Erik, Opioids, Sleep, and Sleep-Disordered Breathing, Current Pharmaceutical Design 2011; 17 (15) . https://dx.doi.org/10.2174/138161211796197070
DOI https://dx.doi.org/10.2174/138161211796197070 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human Ascariasis: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Complex Inheritance for Susceptibility to Sudden Cardiac Death
Current Pharmaceutical Design Treating Depression in Coronary Artery Disease and Chronic Heart Failure: What’s new in using Selective Serotonin Re-Uptake Inhibitors?
Cardiovascular & Hematological Agents in Medicinal Chemistry Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology Prostacyclin Analogues: Prevention of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Resistin and Oxidative Stress in Non-Diabetic Obstructive Sleep Apnea Patients with Nocturnal Hypertension
Current Respiratory Medicine Reviews Design and Synthesis of Novel 1,3-Dioxane-2-carboxylic Acid Derivatives as PPARα/γ Dual Agonists
Letters in Drug Design & Discovery Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion
Current Pharmaceutical Design Stress Echocardiography
Current Pharmaceutical Design Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal Chemistry Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry MicroRNAs in the Diagnosis and Treatment of Unstable Angina
Current Topics in Medicinal Chemistry Effects of ACE Inhibitors on Skeletal Muscle
Current Pharmaceutical Design Infection-Associated Biomarkers of Inflammation in Atherosclerosis
Current Pharmaceutical Design Valsartan Protects Against Contrast-Induced Acute Kidney Injury in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis
Current Vascular Pharmacology Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Reactive Oxygen Production Induced by the Gut Microbiota: Pharmacotherapeutic Implications
Current Medicinal Chemistry Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery
Current Medicinal Chemistry Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Current Cardiology Reviews Apoptosis: A Potential Therapeutic Target for Retinal Degenerations
Current Neurovascular Research